Global Varicose Vein Treatment Market by 2024

1
Global Varicose Vein Treatment Market Analysis
And Segment Forecasts To 2024
2
Global Varicose Vein Treatment Market Analysis
And Segment Forecasts To 2024

• The global varicose vein treatment market is
  expected to reach USD 475 million by 2024,
  according to a new report by Grand View Research,
  Inc. The increasing technological advancements
  coupled with the increased availability of the
  advanced varicose vein treatment devices and
  shift towards less-invasive procedures are the
  contributing factors for the growth of the
  market.
• Browse the reporthttp//www.orbisresearch.com/re
  ports/index/varicose-vein-treatment-market-analysi
  s-by-treatment-mode-sclerotherapy-endovenous-ablat
  ion-stripping-laser-radiofrequency-ablation-and-se
  gment-forecasts-to-2024
• The huge burden of vascular diseases in Europe
  and North America and the increasing patient
  compliance and reliability, growth in healthcare
  expenditure, and the rapid growth in geriatric
  population is majorly driving the varicose vein
  procedure market.
• The upward trend in lifestyle disorders, such as
  increasing obesity, sleep disorders, blood
  pressure levels, hormonal changes, genetic
  disorders and pregnancy are the few major factors
  contributing to the peripheral vascular diseases.
  Untreated venous insufficiency, such as varicose
  vein and venous ulcers cause progressive
  syndromes including chronic veinous
  insufficiency.

3
Global Varicose Vein Treatment Market Analysis
And Segment Forecasts To 2024

• Some key players of the market include
  Quanta Systems S.p.A, Vascular Solutions, Inc.,
  Eufoton S.R.L, Energist Group, Medtronic plc,
  Dornier MedTech GmbH, Lumenis Ltd., Syneron
  Medical Ltd., Biolitec AG, and AngioDynamics,
  Inc.
• Request a sample of the report
  http//www.orbisresearch.com/contacts/request-samp
  le/106351
• AngioDynamics, Inc. and MerzPharma GmbH Co.
  KGaAin North America established a multi-year
  relationship to market Asclera for patients with
  peripheral vascular diseases.In the
  U.S,.MerzPharma GmbH Co. KGaAserves as the
  exclusive distributor of the Asclera Injection.
  Asclera is approved for the treatment of spider
  and reticular veins, which showed good
  improvement in 95 of the patients treated with
  asclera.
• In 2016, Medtronic plc acquired Italian
  hemodialysis player Bellco, Inc.This acquisition
  is projected to enable the medical device giant
  to gain market position in newly formed renal
  care solution business.

4
Global Varicose Vein Treatment Market Analysis
And Segment Forecasts To 2024

• About Us
• Orbis Research (orbisresearch.com) is a
  single point aid for all your market research
  requirements. We have vast database of reports
  from the leading publishers and authors accross
  the globe. We specialize in delivering customised
  reports as per the requirements of our clients.
  We have complete information about our publishers
  and hence are sure about the accuracy of the
  industries and verticals of their specialisation.
  This helps our clients to map their needs and we
  produce the perfect required market research
  study for our clients.
• Contact Information
• 4144N Central Expressway,
• Suite 600, Dallas,
• Texas - 75204, U.S.A.
• Phone No. 1 [phone]
• enquiry_at_orbisresearch.com
• sales_at_orbisresearch.com